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• Policy (e.g. national treatment guidelines 
for OUD) 
• Health systems (e.g. financing, 
structure: integration of OUD treatment 
with other care) 
• Economic environment (e.g. coverage 
of treatment services) 
• Legal environment (e.g. criminalization 
of drug use, drug courts) 




stigma towards drug 
use, race/ethnicity) 
• Networks and 
dependencies (e.g. 














• Personal beliefs 
about OUD, and 
treatment 
• History of heroin 







(waiting list for clinic, 
providers) 

































• Other medical co-
morbidities (HIV, HCV, 
Psychiatric) 
•Prior treatment history 
(methadone, 
buprenorphine, detox) 
• History of heroin use 
(vs. opioid pills only) 
 
Year of enrollment  
(policy, legal or economic 
changes) 
























































































































































































































37	(28,	46)	 37	(28,	46)	 38	(28,	46)	 0.76	





























634	(64.3	%)	 391	(65.9%)	 243	(61.8%)	 0.50	
Unemployed		
(N	=	1177)	
752	(60.8%)	 389	(59.8%)	 363	(69.7%)	 <.0001	
Any	Psychiatric	
Diagnoses	(N	=	1224)	
808	(66.0%)	 482	(72.9%)	 326	(57.9%)	 <.0001	
HIV	Positive	(N	=	469)	 23	(4.9%)	 10	(3.7%)	 13	(6.5%)	 0.16	
HCV	Antibody	Positive	
(N	=	1084)	
636	(58.7%)	 306	(52.2%)	 330	(66.3%)	 <.0001	
Alcohol	Use	at	
Enrollment	(N	=1237)	
213	(17.2%)	 96	(14.5%)	 117	(20.4%)	 0.006	
Cocaine	Use	at	
Enrollment	(N	=	1237)	




108	(8.7	%)	 51	(7.7%)	 57	(9.9%)	 0.16	
Ever	heroin	use		
(N	=	1237)	
1063	(85.9%)	 547	(82.4%)	 516	(90.1%)	 0.0001	
Prior	Buprenorphine	
Treatment	(N	=	1237)	
404	(32.7%)	 241	(36.3%)	 163	(28.4%)	 0.003	
Age	at	first	Opioid	Use	
(N=1164)	






























































































































































































Relapse	 523	(32.6%)	 167	(23.3%)	 356	(40.1%)	
Taper	 53	(3.3%)	 33	(4.6%)	 20	(2.3%)	
Legal	Issues	 62	(3.9%)	 20	(2.8%)	 42	(4.7%)	
Transfer	 86	(5.4%)	 40	(5.6%)	 46	(5.2%)	
Insurance	issues	 7	(0.4%)	 6	(0.8%)	 1	(0.1%)	
Death	 0	(0%)	 0	(0%)	 0	(0%)	
Unknown	 492	(30.6%)	 162	(22.6%)	 330	(37.2%)	
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